ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
股权激励
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Astellas Pharma, Inc.
15.42
+0.0900
0.59%
成交量:
2.23万
成交额:
34.51万
市值:
276.01亿
市盈率:
207.35
高:
15.95
开:
15.43
低:
15.41
收:
15.33
52周最高:
16.95
52周最低:
8.37
股本:
17.90亿
流通股本:
17.45亿
量比:
0.41
换手率:
0.00%
股息:
0.51
股息率:
3.33%
每股收益(TTM):
0.0744
每股收益(LYR):
0.0628
净资产收益率:
19.82%
总资产收益率:
7.38%
市净率:
2.49
市盈率(LYR):
245.33
数据加载中...
总览
公司
新闻资讯
公告
安斯泰来:EV-304研究中围术期enfortumab vedotin联合帕博利珠单抗的安全性特征与既往联合用药经验一致
美股速递
·
02/27
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠: 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠: 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ALPMY/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ALPMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMY\",,,,,undefined,":{"symbol":"ALPMY","market":"US","secType":"STK","nameCN":"Astellas Pharma, Inc.","latestPrice":15.417,"timestamp":1773244320000,"preClose":15.327,"halted":0,"volume":22323,"delay":15,"changeRate":0.005871990604815023,"floatShares":1745183156,"shares":1790310070,"eps":0.074352,"marketStatus":"交易中","change":0.09,"latestTime":"03-11 11:52:00 EDT 延时","open":15.43,"high":15.95,"low":15.41,"amount":345125.96926499996,"amplitude":0.035232,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.074352,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1773259200000},"marketStatusCode":2,"adr":0,"adrRate":1,"exchange":"PINK LIMITED","adjPreClose":15.327,"volumeRatio":0.410745},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMY\",,,,,undefined,":{"symbol":"ALPMY","floatShares":1745183156,"roa":"7.38%","roe":"19.82%","lyrEps":0.062841,"volumeRatio":0.410745,"shares":1790310070,"dividePrice":0.5133,"high":15.95,"amplitude":0.035232,"preClose":15.327,"low":15.41,"week52Low":8.37,"pbRate":"2.49","psRate":"2.13","week52High":16.95,"institutionHeld":0,"latestPrice":15.417,"eps":0.074352,"divideRate":0.033294,"volume":22323,"delay":15,"ttmEps":0.074352,"open":15.43,"prevYearClose":13.29,"prevWeekClose":14.93,"prevMonthClose":16.51,"prevQuarterClose":13.29,"fiveDayClose":15.14,"twentyDayClose":16.38,"sixtyDayClose":13.207},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALPMY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-04","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1738645200000,"reportTimeType":"","actualEps":null},{"date":"2024-08-01","symbol":"ALPMY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722499200000,"name":null,"time":"","dateTimestamp":1722484800000,"actualEps":null},{"market":"US","date":"2024-04-25","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-02-05","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1707109200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-11-01","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1698811200000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALPMY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALPMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1758254400000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALPMY\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1164144381","title":"安斯泰来:EV-304研究中围术期enfortumab vedotin联合帕博利珠单抗的安全性特征与既往联合用药经验一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1164144381","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164144381?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 23:05","pubTimestamp":1772204701,"startTime":"0","endTime":"0","summary":"根据EV-304研究数据,安斯泰来制药公司公布的最新结果显示,在围术期使用enfortumab vedotin联合帕博利珠单抗的治疗方案,其安全性特征与先前对该联合疗法的经验保持一致。\n这一发现进一步支持了该联合治疗方案在临床应用中的安全性一致性,为后续治疗策略的制定提供了重要参考依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0985481810.HKD","LU0306806265.USD","BK4581","BK4599","LU1883839398.USD","LU0306807586.USD","SG9999002224.SGD","SG9999001176.USD","LU0321505439.SGD","BK4568","LU0225771236.USD","BK4588","BK4585","BK4534","LU1057294990.SGD","SG9999001176.SGD","SG9999002232.USD","LU0122379950.USD","SGXZ57979304.SGD","BK4533","LU1894683348.USD","LU1894683264.USD","IE0002270589.USD","ALPMY","BK4550","LU0868494617.USD","LU0170899867.USD","IE000M9KFDE8.USD","IE00BBT3K403.USD","LU1066053197.SGD","LU1066051498.USD","SG9999013999.USD","BK4592","SG9999011175.SGD","LU0321505868.SGD","LU1023059063.AUD","IE00BLSP4452.SGD","IE00BLSP4239.USD","LU0289739699.SGD","SG9999003800.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0456855351.SGD","LU0225284248.USD","BK4007","LU0234572021.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}